TAAT ™ becomes an official supplier to HT Hackney, one of the largest wholesale distributors in the United States



Receive instant alerts for news on your actions. Claim your 1-week free trial for Street Insider Premium here.


LAS VEGAS and VANCOUVER, British Columbia, November 26, 2021 (GLOBE NEWSWIRE) – TAAT GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT”) is pleased to announce that it has become an official supplier of HT Hackney Company (“HT Hackney”), which is one of the largest wholesale distributors in the United States with a turnover of 3.9 billion US dollars1 and a network of more than 20,000 points of sale in 22 states2. On Monday, November 22, 2021, HT Hackney issued an order form for 168 TAAT ™ counter displays and over 1,000 boxes of TAAT ™ for initial product placement throughout the chain Stores By Mar; which operates numerous outlets in Ohio, West Virginia and Pennsylvania, including convenience stores at gas stations under national banners such as Amoco, British Petroleum (BP), Shell and Sunoco3.

TAAT ™ and HT Hackney are currently coordinating in-store activation strategies with the goal of converting smokers aged 21 and over from purchasing tobacco cigarettes to purchasing TAAT ™ Original, Smooth, Where Menthol instead in Par Mar stores. At the time of this writing, TAAT ™ is expected to hit shelves at Par Mar stores in Ohio, West Virginia and Pennsylvania by Wednesday, December 15, 2021. From In addition, the company believes that TAAT ™ may work particularly well at Par Mar stores located in the state of West Virginia, as this market has the highest rate of adult cigarette smoking in all of the United States at 23.8%4 (about 70% more than the national average of 14%5).

For more information about HT Hackney, please visit the following webpage: https://www.hthackney.com/

For more information on Par Mar stores, please visit the following webpage: https://www.parmarstores.com/

The photos accompanying this announcement are available on:
https://www.globenewswire.com/NewsRoom/AttachmentNg/f7811c83-235c-4b4d-b24c-3293e09737c0
https://www.globenewswire.com/NewsRoom/AttachmentNg/80953e8a-58b3-4a06-9bda-7d32c3fc140c

Readers using news aggregation services may not be able to view the above media. Please access SEDAR or Investor Relations section of the Company’s website for a version of this press release containing all published media.

Setti Coscarella, CEO of TAAT ™, commented: “We have been in discussion with HT Hackney for some time now, and we are very happy to have signed a distribution contract with them after demonstrating the consistent quality of the TAAT product. ™, impressive results. laboratory tests and our ability to reliably and consistently fulfill large orders. From the start of our dialogue with HT Hackney, I knew their team had world-class expertise in the tobacco category, which was instrumental in their success in distributing established brands of tobacco cigarettes in nearly two dozen states. We are very pleased with the first placement of TAAT ™ in Par Mar stores and the associated order of over 1000 boxes as an initial delivery. Through the Par Mar stores, TAAT ™ will be introduced for the first time in the state of West Virginia, which we see as a key strategic market for TAAT ™ as a nicotine and tobacco-free alternative to cigarettes. tobacco. We look forward to seeing the first TAAT ™ performance in Par Mar stores starting in December, as we work with HT Hackney to seek additional channel placement opportunities in their 20,000 store network.

Sources

1 – https://www.forbes.com/companies/ht-hackney/?sh=58d4e4d05169

2 – https://www.hthackney.com/qui-nous-sommes

3 – https://www.parmarstores.com/

4 – https://www.cdc.gov/statesystem/cigaretteuseadult.html

5 – https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_Smoking/index.htm

On behalf of the Board of Directors of the Company,

TAAT WORLDWIDE ALTERNATIVES INC.

“Setti Coscarella”

Setti Coscarella, CEO and Director

For more information, please contact:

TAAT ™ Investor Relations
1-833-TAAT-United States (1-833-822-8872)
[email protected]

THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS COMMUNICATION, NOR THE CSE REGULATORY SERVICE PROVIDER.

About TAAT Global Alternatives Inc.

The Company has developed TAAT ™, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in the “Original”, “Smooth” and “Menthol” varieties. The base material of TAAT ™ is Beyond Tobacco ™, a proprietary blend that undergoes a patent pending refinement technique that makes its scent and taste resemble tobacco. Under the leadership of management with the “Big Tobacco” pedigree, TAAT ™ was first launched in the United States in the fourth quarter of 2020 as the company seeks to position itself in the $ 814 billion mark.1 the global tobacco industry.

For more information, please visit http://taatglobal.com.

The references

1British American Tobacco – The Global Market

Forward-looking statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “believes” , “Intention”, “” anticipates “or” does not anticipate “, or” believes “, or variations of these words and expressions or states that certain actions, events or results” could “,” could “,” would “,” could “or” be “to be taken, to occur or to be achieved. Forward-looking information contained in this press release includes statements regarding the anticipated performance of TAAT ™ in the tobacco industry, in addition to what follows: Placement of TAAT ™ in Par Mar stores (in Ohio, West Virginia and Pennsylvania) by December 15, 2021, performance of TAAT ™ at retail among smokers 21 years and older. management’s current expectations based on information currently available and are subject to a number of risks and uncertainties which may cause the results to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in the preparation of forward-looking information are reasonable, such information should not be relied on unduly and no assurance can be given that such events will occur within the time disclosed or in the future. all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes in the growth and size of tobacco markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly changing environment. New risk factors emerge from time to time, and it is impossible for the management of the Company to predict all risk factors, nor can the Company assess the impact of all factors on the business of the Company. Company or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. , unless required by applicable law.

The statements contained in this press release have not been evaluated by Health Canada or the United States Food and Drug Administration. Because everyone is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claim or guarantee can be made as to the effects of the Company’s products on the health and well-being of an individual. The Company’s products are not intended to diagnose, treat, cure or prevent any disease.

This press release may contain brand names of third party entities (or their respective offerings with brand names) generally in reference to (i) the relationship between the Company and third party entities mentioned in this release and / or (ii ) the client / supplier / service provider parties whose relationship with the Company is / are mentioned in this press release. All rights to these trademarks are reserved by their respective owners or licensees.

Statement Regarding Third Party Investor Relations Firms

Information relating to the investor relations companies retained by TAAT ™ Global Alternatives Inc. can be found under the company profile on http://sedar.com.

About Margaret Shaw

Check Also

Top FDA tobacco official resigns to take job at Philip Morris International

OOn July 26, Matthew Holman, director of the Food and Drug Administration’s Center for Tobacco …